SCHEMBL2465093

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL12175816	0.93	—	—
	SCHEMBL2585716	0.89	TUBB4A (0.33)	TUBB4ATUBBTUBA3CTUBA1BTUBA4A
	SCHEMBL2575582	0.89	ABCB1 (0.33)	TUBB4ATUBBTUBA3CTUBA1BTUBA4A
	SCHEMBL2464402	0.88	ESR1 (0.33)	—
	SCHEMBL2587899	0.88	ABCB1 (0.30)	ABCB1
	SCHEMBL12160480	0.86	ABCB1 (0.31)	ABCB1
	SCHEMBL2466827	0.84	MAOB (0.34)	—
	SCHEMBL2467694	0.82	CHRM1 (0.35)	—
	SCHEMBL2461274	0.82	TUBB4A (0.36)	TUBB4ATUBBTUBA3CTUBA1BTUBA4A
	SCHEMBL12175815	0.82	ESR1 (0.31)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.